Akums Drugs and Pharmaceuticals Limited has submitted a certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate confirms compliance for the quarter ended December 31, 2025. The confirmation was received from MUFG Intime India Private Limited, the company's Registrar & Share Transfer Agent (RTA). The RTA confirmed that securities received from depository participants for dematerialisation during the quarter were processed (accepted/rejected) and listed on the stock exchanges. They also verified that the security certificates were mutilated and cancelled after due verification, and the depositories were substituted as the registered owner within the prescribed timelines. This information is for the record and information of the exchanges.
